IL156957A0 - Use of rhein for preparing a medicine for treating a high level of il-1 - Google Patents

Use of rhein for preparing a medicine for treating a high level of il-1

Info

Publication number
IL156957A0
IL156957A0 IL15695702A IL15695702A IL156957A0 IL 156957 A0 IL156957 A0 IL 156957A0 IL 15695702 A IL15695702 A IL 15695702A IL 15695702 A IL15695702 A IL 15695702A IL 156957 A0 IL156957 A0 IL 156957A0
Authority
IL
Israel
Prior art keywords
rhein
medicine
treating
preparing
high level
Prior art date
Application number
IL15695702A
Other languages
English (en)
Original Assignee
Negma Lerads
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Negma Lerads filed Critical Negma Lerads
Publication of IL156957A0 publication Critical patent/IL156957A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Emergency Medicine (AREA)
  • Immunology (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IL15695702A 2001-01-23 2002-01-23 Use of rhein for preparing a medicine for treating a high level of il-1 IL156957A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/768,816 US20020128317A1 (en) 2001-01-23 2001-01-23 Treatment of pathological conditions characterized by an increased IL-1 level
PCT/FR2002/000271 WO2002058681A2 (fr) 2001-01-23 2002-01-23 Utilisation d'une rhéine pour la préparation d'un médicament pour le traitement d'un taux élevé d'il-1.

Publications (1)

Publication Number Publication Date
IL156957A0 true IL156957A0 (en) 2004-02-08

Family

ID=25083563

Family Applications (1)

Application Number Title Priority Date Filing Date
IL15695702A IL156957A0 (en) 2001-01-23 2002-01-23 Use of rhein for preparing a medicine for treating a high level of il-1

Country Status (7)

Country Link
US (1) US20020128317A1 (xx)
EP (1) EP1363613A2 (xx)
AU (1) AU2002231927A1 (xx)
CA (1) CA2434052A1 (xx)
IL (1) IL156957A0 (xx)
MX (1) MXPA03006596A (xx)
WO (1) WO2002058681A2 (xx)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6797727B2 (en) * 2001-07-16 2004-09-28 Transition Therapeutics Inc. Use of rhein or diacerhein compounds for the treatment or prevention of vascular diseases
FR2842738B1 (fr) * 2002-07-23 2006-02-10 Negma Lerads Utilisation d'une rheine pour la preparation d'un medicament pour le traitement de l'inflammation chronique, la prevention et le traitement du rejet des transplantations d'organes et de tissus
CN1314361C (zh) * 2003-04-02 2007-05-09 李安虎 一种关节保健饮品或食品及其制备方法
MXPA04009698A (es) * 2004-10-04 2006-04-05 Maria Elena Garcia Armenta Formulaciones farmaceuticas solidas conteniendo diacereina y meloxicam.
WO2009034409A2 (en) * 2007-09-14 2009-03-19 Wockhardt Research Centre Pharmaceutical compositions of rhein or diacerein
FR2920991A1 (fr) * 2007-09-14 2009-03-20 Wockhardt Ltd Composition a base de diacerheine pour le traitement de l'arthrose
EP2060562A1 (en) * 2007-11-16 2009-05-20 Laboratoire Medidom S.A. Dioxoanthracene sulphonate derivatives
US9119819B2 (en) * 2008-04-30 2015-09-01 Wockhardt Ltd. Oral liquid compositions of rhein or diacerein
TWI743047B (zh) * 2015-08-17 2021-10-21 安成生物科技股份有限公司 使用雙醋瑞因或其類似物抑制asc表現、nlrp3表現、以及/或nlrp3發炎體複合物的形成之方法
TW201739448A (zh) * 2016-05-06 2017-11-16 安成生物科技股份有限公司 用於治療及/或預防血液相關疾病之方法及配方
JP7084930B2 (ja) * 2017-01-18 2022-06-15 タイレックス， インコーポレーテッド 炎症性腸疾患及び腸管大腸炎を処置するのに使用するための組成物

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA761627B (en) * 1976-03-16 1978-01-25 C Friedmann Improvements in or relating to the treatment of arthritis
GB9417102D0 (en) * 1994-08-24 1994-10-12 Lilly Industries Ltd Pharmaceutical compounds
NL1003503C2 (nl) * 1996-07-04 1998-01-07 Negma Steba International Dev Farmaceutische samenstelling voor orale toediening.
IT1283772B1 (it) * 1996-07-31 1998-04-30 Medidom Lab Procedimento per la preparazione di reina e diacereina
IT1283771B1 (it) * 1996-07-31 1998-04-30 Medidom Lab Procedimento per la preparazione di derivati della reina
JP4049406B2 (ja) * 1996-10-15 2008-02-20 正規 小菅 津液改善剤及びそれを含有する経口投与用組成物
JP4018764B2 (ja) * 1996-10-18 2007-12-05 正規 小菅 津液改善用皮膚外用剤
FR2757397B1 (fr) * 1996-12-23 1999-03-05 Mazal Pharma Composition pharmaceutique a base de rheine ou de diacerheine a biodisponibilite amelioree
AR026801A1 (es) * 2000-01-12 2003-02-26 Medidom Lab Sustancias para uso en el tratamiento de la psoriasis

Also Published As

Publication number Publication date
CA2434052A1 (fr) 2002-08-01
WO2002058681A8 (fr) 2003-03-06
MXPA03006596A (es) 2004-05-05
WO2002058681A2 (fr) 2002-08-01
US20020128317A1 (en) 2002-09-12
WO2002058681A3 (fr) 2002-12-19
EP1363613A2 (fr) 2003-11-26
AU2002231927A1 (en) 2002-08-06

Similar Documents

Publication Publication Date Title
PL370818A1 (en) Dosage form for treatment of diabetes mellitus
HK1155649A1 (en) Dosage unit comprising a prostaglandin analog for treating constipation
AU2002342613A8 (en) Treatment for wounds
HK1070285A1 (en) Pharmaceutical dosage form of amorphous nelfinavirmesylate
IL159621A0 (en) Disposable vessel
HK1116339A1 (en) Methods of administering epothilone analogs for the treatment of cancer
GB0512560D0 (en) Bioreactors for well treatment
PT1531819E (pt) Utilização de inibidores da i capa b cinase na terapia da dor
IL137430A0 (en) A series of new illuminating devices for medical use
HUP0400024A3 (en) Combination for treatment of neoplastic diseases
AU2002227958A1 (en) Use of moulding compounds for producing treatment devices
IL156957A0 (en) Use of rhein for preparing a medicine for treating a high level of il-1
GB2376892B (en) Medical needle removal device
IL161748A0 (en) New use for the treatment of gastroesophageal reflux
HRP20030677A2 (en) Methods of administering epothilone analogs for the treatment of cancer
IL162509A (en) Use of deoxypeganine for the production of a drug for treating clinical depression
AU9545701A (en) Use of carp inhibitors for the treatment of heart diseases
IL155237A0 (en) Combination therapy for the treatment of estrogen-sensitive disease
IL154011A0 (en) Treatment of wounds
GB0212790D0 (en) Medicament for the treatment of diabetes
SI1427420T1 (sl) Uporaba kombinacije, ki vsebuje 4-piridilmetilftalazine za zdravljenje raka
PL349481A1 (en) Therapeutic preparation against hypoferremia
GB2383947B (en) Medical apparatus for relief of pain
TW484416U (en) Device dedicated for making medicine plaster
TW515233U (en) Structure of physical filter for breeding